10-Q Filing

ALKERMES PLC. CIK: 1520262 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001520262-17-000039`
Period End Date	20170630
Filing Date	20170727
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	alks-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 92 Cash Flow Statement 61 Comprehensive Income 4

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock shares, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock shares, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock shares, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred stock shares, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$186.38M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$196.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$158.11M	USD	Point-in-time
Preferred stock shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$181.11M	USD	Point-in-time
Preferred stock shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments - short-term	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$317.00M	USD	Point-in-time
Preferred stock shares, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock shares, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investments - short-term	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$310.86M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$191.10M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$199.71M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	450.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	450.00M	shares	Point-in-time
Inventory	`InventoryNet`	$77.35M	USD	Point-in-time
Inventory	`InventoryNet`	$63.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	155.70M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	154.19M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$43.46M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$39.34M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	153.65M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$795.63M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	152.43M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$790.68M	USD	Point-in-time
Treasury stock shares	`TreasuryStockCommonShares`	1.76M	shares	Point-in-time
INTANGIBLE ASSETS - NET	`IntangibleAssetsNetExcludingGoodwill`	$287.45M	USD	Point-in-time
Treasury stock shares	`TreasuryStockCommonShares`	2.05M	shares	Point-in-time
INTANGIBLE ASSETS - NET	`IntangibleAssetsNetExcludingGoodwill`	$318.23M	USD	Point-in-time
PROPERTY, PLANT AND EQUIPMENT, NET	`PropertyPlantAndEquipmentNet`	$264.79M	USD	Point-in-time
PROPERTY, PLANT AND EQUIPMENT, NET	`PropertyPlantAndEquipmentNet`	$266.48M	USD	Point-in-time
GOODWILL	`Goodwill`	$92.87M	USD	Point-in-time
GOODWILL	`Goodwill`	$92.87M	USD	Point-in-time
INVESTMENTS - LONG-TERM	`MarketableSecuritiesNoncurrent`	$121.93M	USD	Point-in-time
INVESTMENTS - LONG-TERM	`MarketableSecuritiesNoncurrent`	$85.72M	USD	Point-in-time
CONTINGENT CONSIDERATION	`BusinessCombinationContingentConsiderationAssetNoncurrent`	$65.50M	USD	Point-in-time
CONTINGENT CONSIDERATION	`BusinessCombinationContingentConsiderationAssetNoncurrent`	$63.20M	USD	Point-in-time
DEFERRED TAX ASSETS	`DeferredTaxAssetsGrossNoncurrent`	$47.77M	USD	Point-in-time
DEFERRED TAX ASSETS	`DeferredTaxAssetsGrossNoncurrent`	$112.33M	USD	Point-in-time
OTHER ASSETS	`OtherAssetsNoncurrent`	$25.35M	USD	Point-in-time
OTHER ASSETS	`OtherAssetsNoncurrent`	$26.96M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.73B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.73B	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$219.84M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$207.06M	USD	Point-in-time
Long-term debt - short-term	`LongTermDebtCurrent`	$3.00M	USD	Point-in-time
Long-term debt - short-term	`LongTermDebtCurrent`	$3.00M	USD	Point-in-time
Deferred revenue - short-term	`DeferredRevenueCurrent`	$1.94M	USD	Point-in-time
Deferred revenue - short-term	`DeferredRevenueCurrent`	$1.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$211.99M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$224.64M	USD	Point-in-time
LONG-TERM DEBT	`LongTermDebtNoncurrent`	$280.67M	USD	Point-in-time
LONG-TERM DEBT	`LongTermDebtNoncurrent`	$279.55M	USD	Point-in-time
OTHER LONG-TERM LIABILITIES	`OtherLiabilitiesNoncurrent`	$17.16M	USD	Point-in-time
OTHER LONG-TERM LIABILITIES	`OtherLiabilitiesNoncurrent`	$18.28M	USD	Point-in-time
DEFERRED REVENUE - LONG-TERM	`DeferredRevenueNoncurrent`	$7.12M	USD	Point-in-time
DEFERRED REVENUE - LONG-TERM	`DeferredRevenueNoncurrent`	$6.78M	USD	Point-in-time
Total liabilities	`Liabilities`	$516.94M	USD	Point-in-time
Total liabilities	`Liabilities`	$529.26M	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred shares, par value, $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at June 30, 2017 and December 31, 2016, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred shares, par value, $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at June 30, 2017 and December 31, 2016, respectively	`PreferredStockValue`	-	USD	Point-in-time
Ordinary shares, par value, $0.01 per share; 450,000,000 shares authorized; 155,695,975 and 154,191,281 shares issued; 153,650,197 and 152,430,514 shares outstanding at June 30, 2017, and December 31, 2016, respectively	`CommonStockValue`	$1.55M	USD	Point-in-time
Ordinary shares, par value, $0.01 per share; 450,000,000 shares authorized; 155,695,975 and 154,191,281 shares issued; 153,650,197 and 152,430,514 shares outstanding at June 30, 2017, and December 31, 2016, respectively	`CommonStockValue`	$1.54M	USD	Point-in-time
Treasury shares, at cost (2,045,778 and 1,760,767 shares at June 30, 2017 and December 31, 2016, respectively)	`TreasuryStockCommonValue`	$89.22M	USD	Point-in-time
Treasury shares, at cost (2,045,778 and 1,760,767 shares at June 30, 2017 and December 31, 2016, respectively)	`TreasuryStockCommonValue`	$72.64M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.29B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.23B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.33M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.27M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-998.30M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-947.94M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$1.20B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$1.21B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.73B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.73B	USD	Point-in-time

Income Statement 92 line items

Line Item	Tag	Value	Unit	Period
Manufacturing and royalty revenues	`ManufacturingAndRoyaltyRevenues`	$129.25M	USD	1 Quarter
Manufacturing and royalty revenues	`ManufacturingAndRoyaltyRevenues`	$243.19M	USD	2 Qtrs
Manufacturing and royalty revenues	`ManufacturingAndRoyaltyRevenues`	$137.03M	USD	1 Quarter
Manufacturing and royalty revenues	`ManufacturingAndRoyaltyRevenues`	$243.93M	USD	2 Qtrs
Product sales, net	`SalesRevenueGoodsNet`	$165.21M	USD	2 Qtrs
Product sales, net	`SalesRevenueGoodsNet`	$57.52M	USD	1 Quarter
Product sales, net	`SalesRevenueGoodsNet`	$106.89M	USD	2 Qtrs
Product sales, net	`SalesRevenueGoodsNet`	$88.76M	USD	1 Quarter
Research and development revenue	`ContractsRevenue`	$833.00K	USD	1 Quarter
Research and development revenue	`ContractsRevenue`	$612.00K	USD	1 Quarter
Research and development revenue	`ContractsRevenue`	$1.48M	USD	2 Qtrs
Research and development revenue	`ContractsRevenue`	$1.85M	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$195.16M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$410.62M	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$218.84M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$351.94M	USD	2 Qtrs
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsSold`	$34.00M	USD	1 Quarter
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsSold`	$61.71M	USD	2 Qtrs
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsSold`	$39.77M	USD	1 Quarter
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsSold`	$80.19M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$198.08M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$97.01M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$203.99M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$99.15M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$108.95M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$96.12M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$211.05M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$185.84M	USD	2 Qtrs
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$15.47M	USD	1 Quarter
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$30.77M	USD	2 Qtrs
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$30.31M	USD	2 Qtrs
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$15.16M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$526.00M	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$263.35M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$475.94M	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$242.28M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-115.38M	USD	2 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-44.51M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-124.00M	USD	2 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-47.12M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$994.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.00M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.17M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.11M	USD	2 Qtrs
Interest expense	`InterestExpense`	$2.92M	USD	1 Quarter
Interest expense	`InterestExpense`	$3.32M	USD	1 Quarter
Interest expense	`InterestExpense`	$6.62M	USD	2 Qtrs
Interest expense	`InterestExpense`	$5.69M	USD	2 Qtrs
Increase in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$2.30M	USD	2 Qtrs
Increase in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$700.00K	USD	1 Quarter
Increase in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$2.20M	USD	1 Quarter
Increase in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$4.10M	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-1.62M	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-467.00K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-119.00K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-218.00K	USD	2 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-596.00K	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-2.89M	USD	2 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-1.17M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-731.00K	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-47.71M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-124.73M	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-118.27M	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-45.68M	USD	1 Quarter
INCOME TAX BENEFIT	`IncomeTaxExpenseBenefit`	$-6.39M	USD	2 Qtrs
INCOME TAX BENEFIT	`IncomeTaxExpenseBenefit`	$-520.00K	USD	1 Quarter
INCOME TAX BENEFIT	`IncomeTaxExpenseBenefit`	$-116.00K	USD	2 Qtrs
INCOME TAX BENEFIT	`IncomeTaxExpenseBenefit`	$-2.68M	USD	1 Quarter
NET LOSS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-124.62M	USD	2 Qtrs
NET LOSS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-43.00M	USD	1 Quarter
NET LOSS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-47.19M	USD	1 Quarter
NET LOSS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-111.88M	USD	2 Qtrs
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.28	USD	1 Quarter
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.73	USD	2 Qtrs
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.31	USD	1 Quarter
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.82	USD	2 Qtrs
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	153.05M	shares	2 Qtrs
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	151.30M	shares	1 Quarter
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	151.06M	shares	2 Qtrs
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	153.39M	shares	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-124.62M	USD	2 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-43.00M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-47.19M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-111.88M	USD	2 Qtrs
Holding (loss) gain, net of a tax (benefit) provision of $(71), $149, $(49) and $574, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.25M	USD	2 Qtrs
Holding (loss) gain, net of a tax (benefit) provision of $(71), $149, $(49) and $574, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-133.00K	USD	1 Quarter
Holding (loss) gain, net of a tax (benefit) provision of $(71), $149, $(49) and $574, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-61.00K	USD	2 Qtrs
Holding (loss) gain, net of a tax (benefit) provision of $(71), $149, $(49) and $574, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$315.00K	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-123.37M	USD	2 Qtrs
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-43.13M	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-46.88M	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-111.94M	USD	2 Qtrs

Cash Flow Statement 61 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-124.62M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-111.88M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$45.79M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$48.27M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$50.89M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$43.85M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-8.89M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-6.86M	USD	2 Qtrs
Excess tax benefit from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$4.61M	USD	2 Qtrs
Increase in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$2.30M	USD	2 Qtrs
Increase in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$700.00K	USD	1 Quarter
Increase in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$2.20M	USD	1 Quarter
Increase in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$4.10M	USD	2 Qtrs
Other non-cash charges	`OtherNoncashExpense`	$3.53M	USD	2 Qtrs
Other non-cash charges	`OtherNoncashExpense`	$1.14M	USD	2 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$29.52M	USD	2 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$8.61M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$14.59M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$13.24M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesAndOtherAssets`	$5.57M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesAndOtherAssets`	$13.41M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$12.70M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$13.40M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-473.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-923.00K	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$5.03M	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$2.70M	USD	2 Qtrs
Cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-36.20M	USD	2 Qtrs
Cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-86.09M	USD	2 Qtrs
Additions of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.28M	USD	2 Qtrs
Additions of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.66M	USD	2 Qtrs
Proceeds from the sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$81.00K	USD	2 Qtrs
Proceeds from the sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$7.00K	USD	2 Qtrs
Investment in Reset Therapeutics, Inc.	`PaymentsToAcquireEquityMethodInvestments`	$15.00M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$169.62M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$160.55M	USD	2 Qtrs
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$190.64M	USD	2 Qtrs
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$307.95M	USD	2 Qtrs
Cash flows provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$101.13M	USD	2 Qtrs
Cash flows provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$9.44M	USD	2 Qtrs
Proceeds from the issuance of ordinary shares under share-based compensation arrangements	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$7.49M	USD	2 Qtrs
Proceeds from the issuance of ordinary shares under share-based compensation arrangements	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$16.40M	USD	2 Qtrs
Excess tax benefit from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$4.61M	USD	2 Qtrs
Employee taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$16.42M	USD	2 Qtrs
Employee taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$8.43M	USD	2 Qtrs
Principal payments of long-term debt	`RepaymentsOfLongTermDebt`	$3.38M	USD	2 Qtrs
Principal payments of long-term debt	`RepaymentsOfLongTermDebt`	$1.50M	USD	2 Qtrs
Cash flows (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$289.00K	USD	2 Qtrs
Cash flows (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.51M	USD	2 Qtrs
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$15.33M	USD	2 Qtrs
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-28.27M	USD	2 Qtrs
CASH AND CASH EQUIVALENTS - Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$181.11M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$196.44M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$186.38M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$158.11M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - End of period	`CashAndCashEquivalentsAtCarryingValue`	$181.11M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - End of period	`CashAndCashEquivalentsAtCarryingValue`	$196.44M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - End of period	`CashAndCashEquivalentsAtCarryingValue`	$186.38M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - End of period	`CashAndCashEquivalentsAtCarryingValue`	$158.11M	USD	Point-in-time
Purchased capital expenditures included in accounts payable and accrued expenses	`NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1`	$4.53M	USD	2 Qtrs
Purchased capital expenditures included in accounts payable and accrued expenses	`NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1`	$2.80M	USD	2 Qtrs

Comprehensive Income 4 line items

Line Item	Tag	Value	Unit	Period
Tax provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$574.00K	USD	2 Qtrs
Tax provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$149.00K	USD	1 Quarter
Tax provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-71.00K	USD	1 Quarter
Tax provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-49.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.